ClinicalTrials.Veeva

Menu

Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO) (ECMO PFA-100)

R

Rennes University Hospital

Status

Terminated

Conditions

Patients With ECMO

Study type

Observational

Funder types

Other

Identifiers

NCT03248596
35RC15_3023_ECMO PFA-100

Details and patient eligibility

About

The aim of the study is a better understanding of hemorrhagic events causes in patients with ECMO, prevent them and decrease the number of transfusion.

Full description

The most frequent complication during ECMO is hemorrhage especially as a curative anticoagulant treatment is necessary. The primary hemostasis is also affected with a von Willebrand disease and thrombopathy, well known but not studied by recent tests.The identification of primary haemostasis deficits with these tools would allow to supply them and decrease the morbi-mortality related to the transfusion.

Enrollment

5 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient older than 18 years old
  • Patient with ECMO
  • Patient hospitalized in an intensive care unit at the University Hospital of Rennes

Exclusion criteria

  • Known history for constitutional pathology of the primary haemostasis
  • Platelets < 100000 / mm3 or hematocrit < 28 % between H+12 and H+24

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems